Etoposide and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Etoposide (etoposide), especially for people who are female, 10-19 old, also take Cyclophosphamide, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Otitis when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,409 drugs and 1,836 conditions by eHealthMe. Check the latest studies of Otitis.

On Aug, 05, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 19 people (0.02%) have Otitis.

Among these 19 people:

What is the gender of people who have Otitis when taking Etoposide? *

female: 75 %
male: 25 %

What is the age of people who have Otitis when taking Etoposide? *

What are other drugs people take besides Etoposide? *

What are other side effects people have besides Otitis? *

Sinusitis (inflammation of sinus): 10 people, 52.63%
Fever: 7 people, 36.84%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 31.58%
Viral Infection: 6 people, 31.58%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 31.58%
Depression: 5 people, 26.32%
Osteochondritis (a painful type of osteochondritis where the cartilage or bone in a joint is inflamed): 5 people, 26.32%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 26.32%
High Blood Cholesterol: 5 people, 26.32%
Hilar Lymphadenopathy (disease of the lymph nodes due to infection): 5 people, 26.32%

What are the existing conditions these people have? *

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 5 people, 26.32%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 26.32%
Multiple Myeloma (cancer of the plasma cells): 4 people, 21.05%
Retinoblastoma (tumour of retina): 1 person, 5.26%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 5.26%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 5.26%
Growth Hormone Deficiency: 1 person, 5.26%
Epstein-Barr Viraemia: 1 person, 5.26%
Bone Sarcoma (bone cancer): 1 person, 5.26%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Etoposide (77,815 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,409 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,836 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.